findmyKOL
Clinical trialNCT02903771CompletedPhase 1Interventional

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

SponsorKazia Therapeutics LimitedEnrollment32Fallopian Tube NeoplasmsOvarian NeoplasmsPeritoneal Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Westmead Adults Hospital

    Westmead, New South Wales, Australia

  • Icon Cancer Care

    South Brisbane, Queensland, Australia

  • Flinders Medical Centre

    Adelaide, South Australia, Australia

United States
  • Peggy and Charles Stephenson Cancer Center, Ou Health Sciences Center

    Oklahoma City, Oklahoma, United States

  • Lifespan Cancer Institute, Rhode Island Hospital

    Providence, Rhode Island, United States

  • Mary Crowley Cancer Research Center

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Dec 2016
Primary completion
24 Mar 2020
Completion
24 Mar 2020
Last update posted
19 Sept 2024
Registered enrollment
32
Registry id
NCT02903771
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.